DeutschNewstral
Article
Mmarketwatch.com on 2020-04-27 14:45
Lyra Therapeutics to offer 3.5 million shares in planned IPO, priced at $14 to $16 each
Related news
- MLyra Therapeutics raises $56 million in IPO, priced at high end of rangemarketwatch.com
- MGalera Therapeutics to offer 5 million shares in IPO priced at $14 to $16 eachmarketwatch.com
- MAprea Therapeutics to offer 5 million shares in its IPO, priced at $14 to $16 eachmarketwatch.com
- MADC Therapeutics to offer 7.36 million shares in IPO, priced at $16 to $18 eachmarketwatch.com
- MDyne Therapeutics to offer 10.3 million shares in IPO priced at $16 to $18 eachmarketwatch.com
- MADC Therapeutics to offer 8.1 million shares in planned IPO, priced at $23 to $26 eachmarketwatch.com
- MRapt Therapeutics to offer 3 million shares in planned IPO priced at $12 to $14 eachmarketwatch.com
- MBeam Therapeutics to offer 6.25 million shares in planned IPO priced at $15 to $17 eachmarketwatch.com
- MFreeline Therapeutics to offer 7.35 million ADS in IPO, priced at $16 to $18 eachmarketwatch.com
- MPandion Therapeutics to offer 5.5 million shares in planned IPO, priced at $16 to $18 eachmarketwatch.com
- MTurning Point Therapeutics to sell 7.4 million shares in IPO, priced at $16 to $18 eachmarketwatch.com
- MTrevi Therapeutics to offer 6.7 million shares in planned IPO priced at $14 to $16 eachmarketwatch.com
- MPandion Therapeutics upsizes planned IPO, to offer 7 million shares priced at $16 to $18 eachmarketwatch.com
- MBiotech Nurix Therapeutics to offer 11 million shares in planned IPO, priced at $17 to $18 eachmarketwatch.com
- MBlack Diamond Therapeutics to offer 8.9 million shares in planned IPO, priced at $16 to $18 eachmarketwatch.com
- MVapotherm sells 4 million shares priced at $14 each in IPO to raise $56 millionmarketwatch.com
- MAssetMark Financial to offer 12.5 million shares in planned IPO, priced at $19 to $21 eachmarketwatch.com
- MMedical tech company Vapotech to offer 4 million shares in IPO priced at $14 to $16 eachmarketwatch.com
- MLyra Therapeutics shares soar 32% in trading debutmarketwatch.com
- MPandion Therapeutics' upsized IPO priced at the top of the expected rangemarketwatch.com